New scientific statement from @hfsa.bsky.social & AAHFN! Integrated health technologies are reshaping HF care💻, from telemonitoring to mobile apps to implantables. Benefits include ⬆️QoL & ⬇️hospitalizations, but success depends on many complex factors. 🔗 bit.ly/3Z5bgzb

“This is the era of personalized, precision medicine.” Hear six HFSA past presidents discuss how prevention, genomics, AI, & integrative models of care are reshaping heart failure practice. Listen here: 🔗 https://hfsa.org/heart-failure-beat-hfsa-presidential-voices-leading-modern-era-heart-failure

New #HFBeat episode: Do we actually have evidence for sodium restriction in hospitalized HF management? Here’s Dr. Tariq Ahmad with a quick preview on why the data haven’t delivered clear answers—& why that matters for patient care. Listen here: https://youtube.com/shorts/pliO7q7ftkM?feature=share

The first Issue of 2026 @jcardfail.bsky.social is out now! ▶️A device-based approach to fluid removal ▶️An approve to protect RV failure after LVAD implantation ▶️An HFSA + ASPC scientific statement reframing heart failure as a preventable condition Check it out: www.onlinejcf.com/current

The January edition of the HFSA President's Update, featuring updates from 2025-2026 President Kenneth B. Margulies, MD, FHFSA, is out now! Read the full newsletter >> https://hfsa.org/hfsa-presidents-update-january-2026

@crfheart.bsky.social THT - Technology and Heart Failure Therapeutics Dates: March 2-4, 2026 Location: In person, Boston, MA Learn more >> www.thtmeeting.com #CardioSky #MedSky

We are pleased to welcome December's new HFSA members to our community! Meet the new members and check out upcoming events and key dates for January 🗓️ https://hfsa.org/welcoming-decembers-new-hfsa-members

“What brought you to heart failure?” In this special episode, six HFSA past presidents share the defining moments, mentors, and clinical experiences that shaped their careers. Listen here: 🔗 https://hfsa.org/heart-failure-beat-hfsa-presidential-voices-leading-modern-era-heart-failure #HFBeat

Trial Tinder: Where Clinical Trials Meet Their Match 🔥 Rapid-fire, 5-minute pitches, clinicians present cutting-edge studies seeking clinical partners. Ready to run a trial or hear what’s next in HF device research? Trial Tinder is your must-attend session! Learn more: hfsa.org/asm/hfsa-dev...

#HFSA2025 Early Bird Registration is now open! Here's how you can claim the lowest prices of the year: ✅ Become an HFSA member ✅ Register before June 30 to claim the early bird discount ✅ Save $100 when you register for both ASM 2025 and the HFSA Devices in HF Meeting hfsa.org/asm/registra...

Join us for our latest HF Seminar on June 17 at 5 PM ET! The seminar will feature co-authors Sarah Chuzi, MD, MSc, and Haider Warraich, MD, as they highlight key takeaways. Read the consensus doc in @jcardfail.bsky.social and register: hfsa.org/heart-failur...

Thinking about joining HFSA?! Now is the time to become a first-time member 😍 Get 50% off HFSA Membership AND Discounted ASM Registration today through June 30. Join today: members.hfsa.org/become-a-mem...

The ASM 2025 Clinical Trial Central Submission Window is now open! 🚨 This is your opportunity to gain publicity for your work and get complimentary registration to ASM! Learn more: hfsa.org/asm/clinical...

Checking in from Boston 👋 Dr. Jason Katz is at the 45th annual #ISHLT Meeting, where experts from around the world are coming together to advance the field of heart & lung transplantation. We’re excited to hear his perspective and to share the key takeaways with you all soon! #JCFI #ISHLT2025

Are women with heart failure being underdiagnosed? @dranulala.bsky.social shares: ‘Women’s natriuretic peptide levels may lead to underdiagnoses, particularly in HFpEF.’ Dive into the latest HF Beat episode for actionable insights on sex-specific HF research. 🎧 Listen here: hfsa.org/heart-failur...

The deadline to apply for FHFSA status is approaching! Here's what you need to qualify: ❤️ Current HFSA member ≥ 2 consecutive years ❤️ 50% of time dedicated to HF ❤️ Certification in HF ❤️ 2 letters of recommendation Apply before May 16: hfsa.org/professional...

Gain practical strategies to manage complex cardiovascular complications while optimizing cancer care in our upcoming HF Seminar! FREE live attendance and credits for members! Register for this case-based seminar now: hfsa.org/heart-failur...

The 2024 HF Stats report reveals a concerning rise in #heartfailure mortality rates, especially in younger and minority patients. Join the #HFBeat podcast as we discuss this critical issue with Dr. Biykem Bozkurt. #CardioSky Listen Now 🎧: hfsa.org/hf-stats-202...

Welcome Dr. Julie Doberne Associate Editor for JCF-I. Dr. Doberne is a cardiac surgeon-informatician & an Assist. Prof. at OHSU. Her research focuses on EHR impact, surgeon workflow, & machine learning-driven image analysis, bridging the gap between surgery & technology.

Welcome JCF-I Associate Editor Dr. Sarah Chuzi. Dr. Chuzi is an Adv HF & Transplant Cardiologist at Northwestern Medicine & Director of Adv HF at the Jesse Brown VA Medical Center. Her work focuses on palliative care in heart failure, aiming to improve goal-concordant & end-of-life care.

Welcome Dr. Anthony Carnicelli Associate Editor for JCF-I. Dr. Carnicelli is an Asst. Prof. of Medicine & Adv HF/Transplant Cardiologist & Director of the Cardiac ICU at Medical University of SC. His research focuses on cardiogenic shock, HF therapies, transplantation, & device development.

👋 JCF-I's Deputy Editor Dr. Nosheen Reza. She is an adv HF + genetic cardiologist at U of Pennsylvania w/ NIH & @accintouch.bsky.social -funded research focused on genetic cardiomyopathies. Among her editorial positions, she served as @hfsa.bsky.social @jcardfail.bsky.social Assoc Editor since 2022

JCF-Intersections (@jcfint.bsky.social) publishes the highest-quality science with a focus on diversity, equity and inclusion, and mentorship as well as a special focus on how multidisciplinary partnerships impact patient care. #CardioSky Submit now: editorialmanager.com/jcf-i/defaul...

Help your patients live better, longer lives while reducing hospitalizations with HFSA Patient Education Modules covering critical topics like HF medications, low-sodium diets, managing chronic conditions, and more. Share this link with your patients to learn more: hfsa.org/hfsa-heart-f...

You're in luck 🍀 Less than 24 hours to submit your science for #HFSA2025! Don't miss your chance to present your abstract to colleagues at the HFSA Annual Scientific Meeting! Your important research deserves to be seen. Submit your general abstract: hfsa.org/asm/submitti...

The March Issue of @jcardfail.bsky.social is now available online! ▶️ Calorie Restriction and Exercise Training in HFpEF ▶️ HF Outcomes Amidst Housing Insecurity ▶️ Integration of Pallative Care into HF Care Check it out: www.onlinejcf.com/current

6 DAYS LEFT 🚨 Share your research with the #heartfailure community! #HFSA2025 is the perfect place to put a spotlight on important research being conducted by researchers at all career levels and disciplines. Submit your science by March 17th! hfsa.org/asm/submitti... #CardioSky

“I hope the Journal of Cardiac Failure-Intersections becomes a forum for innovative discussion, diverse ideas, and scientific curiosity.” – Jason Katz, MD, Editor-in-Chief. Submissions open now! 🔗 editorialmanager.com/jcf-i/defaul... #CardioSky @jcardfail.bsky.social

2025 HFSA Call for Volunteers 📣 Volunteering at HFSA helps you develop professionally, facilitates networking with other heart failure leaders, and will positively impact the heart failure field. Plus, it’s fun and rewarding! Get involved: hfsa.slayte.com/calls/detail...

Congratulations to the remaining finalists of the 2024 Jay N. Cohn New Investigator Award! Alessio Gasperetti, MD, PhD, Fernando Giugni, MD, PhD, and Shoji Satoshi, MD, PhD – your impactful research doesn't go unnoticed. We’re now accepting abstracts for #HFSA2025! >> hfsa.org/asm/submitti...

The global prevalence of HFpEF is ⬆️ & women have 2X lifetime risk. This joint publication w/stellar graphics in #JCF & @AJPCardio explores the risk factors, pathophysiology, presentation & therapies of HFpEF in women. 🔗 bit.ly/431HUVx

We’re excited to announce 2024’s Jay N. Cohn New Investigator Award winner Alvaro Delgado and runner-up Ameesh Isath, MD! If you are a young trainee/investigator, submit your research for #HFSA2025 for a chance to win an investigator award >> hfsa.org/asm/submitti... #CardioSky #HeartFailure

🚨New science alert! HM3 LVADs are associated w/hemodynamic related events like RVF. In this prospective RCT, pts who received a novel RV protection strategy upfront post-LVAD implant had better outcomes & less RVF. #THT2025 🔗: bit.ly/3CEDDN7

#HFWeek2025 is happening NOW! Here's how you can get involved 👇 ❤️ Tell your patients! ❤️ Share #MyHFStory2025 ❤️ Highlight critical HF Stats ❤️ Empower patients, caregivers, and providers to take informed actions Learn more: hfsa.org/hfweek2025

Workload-corrected PCWP normalized to body weight (PCWL) is a recently defined hemodynamic metric that may have value in assessment of HFpEF in interatrial shunt device (IASD) studies. Learn more in our latest Perspectives piece. #THT2025 bit.ly/3WYAEpH

Come see us at #THT2025 - Booth #16! Learn more about submitting your science for publication in JCF-Intersections, get signed up for the latest HFSA Devices in Heart Failure Meeting news, and pick up some #HFSA2025 swag! @jcardfail.bsky.social

New Science 🚨! Seated mPAP reflects hemodynamics during most waking hours. This 🔥 latest study shows how ambulatory seated mPAP monitoring provides valuable insights into short-term responses to isolated changes in HF medication. #THT2025 bit.ly/410fc4W

HFSA welcomes all multidisciplinary heart failure research at #HFSA2025! Present your abstract to colleagues at the ePoster Hub, or share your findings during the moderated Oral Abstract sessions. Submit your science by March 17 - start preparing yours today! >> hfsa.org/asm/submitti...

Jeffrey Kuvin, MD, chair of the proposed American Board of Cardiovascular Medicine, provides an update on the status of the application for a new cardiovascular board >> cvboard.org/pressrelease...

Join in the conversation during #HFWeek2025! We're inviting healthcare professionals to share how preventative measures and specific lifestyle changes have improved their patients' lives using #MyHFStory2025 and #HFWeek2025 on your social channels. #CardioSky Learn more: hfsa.org/heart-failur...

Transitioning from pediatric to adult CV care teams is a stressful & high-risk time for patients. @elenadonaldMD discusses the need for disease-specific transition programs to help support & guide emerging adults & caregivers in this vulnerable phase 🔗https://bit.ly/4gV3izU

🫀 A new study validates the SPICT (Supportive and Palliative Care Indicator Tool), which identifies hospitalized HF pts at high mortality risk. Key Findings: ✔ SPICT-JP +: >3x ⬆️ mort risk ✔ Aids in advance-care planning for EoL decisions. 🔗https://bit.ly/4g0Lou8

CLOSING SOON❗ The ASM 2025 session proposal submission window closes tonight! Scientific Sessions make up the core of the meeting's program, delivering the most innovative, ground-breaking science from across the heart failure field. Submit yours: hfsa.org/asm/session-... #HFSA2025 #CardioSky

NEW CardioBites ▶️ What is the pathogenesis of inflammation as it relates to cardiovascular disease? Inflammation is an important, under-recognized contributor to cardiovascular diseases ranging from atherosclerotic disease to #heartfailure. Discover more: youtu.be/IAnqtZEdKZw #CardioSky

🔬New insights into cardiogenic shock! High cDPP3 levels were associated with: ✔️ Higher 30-day mortality (1.7x risk) ✔️ Increased need for organ support (renal therapy, mechanical ventilation) Learn how cDPP3 kinetics reshape patient outcomes. 🔗 bit.ly/3PAIQs0

🔥#JCF Ignite🔥 There has been an avalanche of positive trials for GLP1a across many diseases but mixed early-phase results in HFrEF. John Ostrominski & @mvaduganathan discuss the urgent need for dedicated trials of GLP1a in HFrEF👇 bit.ly/40ejQfb

Featured in @jcardfail.bsky.social: Heart failure continues to be an escalating challenge for cardiology providers and healthcare clinicians with rising prevalence rates and widening disparities among populations. Learn how to leverage HF Stats >> onlinejcf.com/article/S107... #CardioSky

In the latest issue of @jcardfail.bsky.social, HFSA President Michael Felker, MD, FHFSA, discusses the impact of Hurricane Helene, the value of resilience, and how HFSA plans to move forward in 2025. Read more >> onlinejcf.com/article/S107...

Check out these highlights from the World Symposium on PH, curated specifically for the HF cardiologist 🌎🫀 From phenotyping PH-Left Heart Disease to considering how to incorporate sotatercept, this #JCF piece has you covered with the latest. 🔗 bit.ly/3BZDhjP

🚨Does adaptive CRT pacing improve clinical & economic outcomes? New research showing adaptive CRT algorithm = ⬇️ mortality rates, ⬇️ healthcare resources ⬇️ patient/payer costs. Out now in #JCF! 🔗 bit.ly/40ztAC8